Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ceapro Inc. stock logo
CRPOF
Ceapro
$0.17
$0.17
$0.11
$0.40
$13.31M1.4715,466 shsN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$35.42
+1.9%
$1.90
$33.92
$37.24
$25.89M0.161,370 shs2,893 shs
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$3.22
-2.1%
$3.24
$3.04
$18.00
$4.35M0.73105,261 shs4,700 shs
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
$0.97
$0.37
$1.67
$8K-0.39525,982 shs432 shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.71
-3.4%
$1.74
$0.95
$11.92
$198.41M1.181.19 million shs38,029 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ceapro Inc. stock logo
CRPOF
Ceapro
0.00%0.00%0.00%0.00%0.00%
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
+0.21%-0.21%+1.09%+2.98%-0.51%
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
0.00%0.00%0.00%0.00%-67.51%
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
0.00%0.00%0.00%0.00%0.00%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-3.39%-6.30%-18.96%-31.33%-80.02%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ceapro Inc. stock logo
CRPOF
Ceapro
N/AN/AN/AN/AN/AN/AN/AN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.1601 of 5 stars
0.03.00.00.00.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ceapro Inc. stock logo
CRPOF
Ceapro
0.00
N/AN/AN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.00
N/AN/AN/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
0.00
N/AN/AN/A
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
0.00
N/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ceapro Inc. stock logo
CRPOF
Ceapro
$7.14M1.86$0.06 per share2.74$0.32 per share0.53
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$10K2,656.05N/AN/A$1.26 per share28.11
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$12.25M0.35$0.14 per share23.15$6.39 per share0.50
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
N/AN/AN/AN/A($0.27) per shareN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.93M102.80N/AN/A$243.66 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ceapro Inc. stock logo
CRPOF
Ceapro
-$3.49M-$0.06N/AN/A-69.60%-20.30%-18.07%N/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
-$8.09M-$1.68N/AN/AN/AN/A-104.96%-60.03%N/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$160K$4.870.66N/A22.79%-73.69%-48.17%N/A
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
-$27.05MN/AN/AN/AN/AN/AN/A-234.42%N/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-$3.10MN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ceapro Inc. stock logo
CRPOF
Ceapro
N/AN/AN/AN/AN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$2.105.93%N/AN/A N/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$5.00155.28%N/A102.67%N/A
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
N/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/A

Latest GHSI, EYEG, CRPOF, SXTC, and INNT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14234.81%7/1/20257/1/20257/7/2025
5/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.15075.19%6/2/20256/2/20256/5/2025
4/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$0.15015/1/20255/1/20255/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ceapro Inc. stock logo
CRPOF
Ceapro
N/A
11.00
7.72
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.01
3.07
3.07
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/A
16.68
16.59
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
N/A
0.35
0.35
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Ceapro Inc. stock logo
CRPOF
Ceapro
N/A78.29 millionN/ANot Optionable
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
14750,0005.28 millionNot Optionable
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
101.35 million1.33 millionNot Optionable
Innovate Biopharmaceuticals Inc stock logo
INNT
Innovate Biopharmaceuticals
841.33 millionN/ANot Optionable
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
90116.03 million111.45 millionNot Optionable

Recent News About These Companies

China SXT Pharmaceuticals, Inc. (SXTC) - Yahoo Finance
China SXT Pharmaceuticals Inc Ordinary Shares
China SXT Pharmaceuticals regains compliance with Nasdaq
China SXT Pharmaceuticals Inc trading resumes
China SXT Pharmaceuticals Inc trading halted, volatility trading pause
China SXT Pharmaceuticals Inc trading halted, news pending
china sxt pharmaceuticals - SXTC

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ceapro stock logo

Ceapro OTCMKTS:CRPOF

$0.17 0.00 (0.00%)
As of 06/6/2024

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

AB Corporate Bond ETF stock logo

AB Corporate Bond ETF NASDAQ:EYEG

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Guardion Health Sciences stock logo

Guardion Health Sciences NASDAQ:GHSI

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Innovate Biopharmaceuticals stock logo

Innovate Biopharmaceuticals NASDAQ:INNT

Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase IIb clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase I clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease, as well as product for the treatment of alcoholic steatohepatitis (ASH). In addition, the company holds rights for INN-329, a formulation of secretin that is used to enhance visualization in magnetic resonance cholangiopancreatography procedures that is in Phase III clinical trial. The company has a research collaboration with Massachusetts General Hospital for the treatment of ASH. Innovate Biopharmaceuticals, Inc. is based in Raleigh, North Carolina.

China SXT Pharmaceuticals stock logo

China SXT Pharmaceuticals NASDAQ:SXTC

$1.71 -0.06 (-3.39%)
As of 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.